HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous ganciclovir consistently induces remission of persistent Epstein-Barr encephalitis in an HIV-1-infected patient.

AuthorsAngelos M Katramados, Naganand Sripathi, Indira Brar, Panayiotis D Mitsias
JournalAIDS (London, England) (AIDS) Vol. 21 Issue 6 Pg. 778-80 (Mar 30 2007) ISSN: 0269-9370 [Print] England
PMID17413706 (Publication Type: Case Reports, Letter)
Chemical References
  • Antiviral Agents
  • Ganciclovir
Topics
  • Adult
  • Antiviral Agents (administration & dosage)
  • Encephalitis, Viral (drug therapy)
  • Epstein-Barr Virus Infections (drug therapy)
  • Female
  • Ganciclovir (administration & dosage)
  • HIV Infections (complications)
  • HIV-1
  • Humans
  • Injections, Intravenous
  • Magnetic Resonance Imaging
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: